Our new website is online.

On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade.
Ürünler

Ürünler

Eczacıbaşı-Monrol Nuclear Products realized the production of F18 FDG in 2001 (Florodeoksi-D-glucose) required for the PET (Positron Emission Tomography) which was developed in the world. They also produce the radiopharmaceutical used in SPECT (Single Photon Emission Computed Tomography). 

Nükleer Tıp

Nükleer TıpPositron Emission Tomography (PET Imaging)

What is Nuclear Medicine?

Why do radioactive materials are required for diagnose and treatment of diseases? Do materials used in nuclear medicine inflict any harm?

[01.07.2008]  On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade.

[13-15.03.2008]  "EGYPT NUCLEAR MEDICINE CONGRESS (SNM)"

[15.12.2007]  "ARAB HEALTH - DUBAI "

[07-09.12.2007]  "SYMPOSIUM of MOLECULAR IMAGING, PET and CLINICAL ONCOLOGY"

[15.09.2006]  Setup and Trial processes of machines started at Monrol Adana Production Plant.
CONTACT INFORMATION REPRESENTATIVES IN OTHE COUNTRIES LOCAL REPRESENTATIVES